Department of Neurosurgery, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Department of Neurology, Sir Runrun Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, China.
World Neurosurg. 2022 Jun;162:e580-e586. doi: 10.1016/j.wneu.2022.03.053. Epub 2022 Mar 18.
It remains controversial whether patients with atypical meningiomas can benefit from postoperative radiotherapy (PORT) after gross total resection (GTR). This study aimed to explore the effectiveness of PORT in patients with atypical meningiomas after GTR based on our single-center data with a relatively large sample size.
Patients with atypical meningiomas who underwent GTR in our center were reviewed. Univariable and multivariable Cox proportional hazard models were conducted for survival analyses. Kaplan-Meier survival curves were generated, and 5-year progression-free survival (PFS) rates were calculated.
This study enrolled 260 patients. PORT was not associated with PFS (P = 0.507). Sex (P = 0.006, hazard ratio 0.418, 95% confidence interval 0.224-0.781), age (P = 0.032, hazard ratio 1.032, 95% confidence interval 1.003-1.061), and tumor location (P = 0.026, hazard ratio 0.199, 95% confidence interval 0.048-0.824) were independent predictors of PFS. The 5-year PFS rate of patients receiving PORT (85.6%) was similar to that of patients not receiving PORT (84.8%). The 5-year PFS rate was 100% in patients with convexity atypical meningiomas regardless of whether or not they received PORT.
PORT after GTR may not prolong PFS in patients with atypical meningiomas. Patients with convexity atypical meningiomas had favorable outcomes after GTR regardless of receipt of PORT.
对于大体全切除(GTR)后的非典型脑膜瘤患者,术后放疗(PORT)是否获益仍存在争议。本研究旨在基于我们的单中心、大样本数据,探讨 GTR 后非典型脑膜瘤患者行 PORT 的疗效。
回顾在我院行 GTR 的非典型脑膜瘤患者。采用单变量和多变量 Cox 比例风险模型进行生存分析。生成 Kaplan-Meier 生存曲线,并计算 5 年无进展生存率(PFS)。
本研究共纳入 260 例患者。PORT 与 PFS 无关(P=0.507)。性别(P=0.006,风险比 0.418,95%置信区间 0.224-0.781)、年龄(P=0.032,风险比 1.032,95%置信区间 1.003-1.061)和肿瘤位置(P=0.026,风险比 0.199,95%置信区间 0.048-0.824)是 PFS 的独立预测因素。行 PORT 治疗的患者 5 年 PFS 率(85.6%)与未行 PORT 治疗的患者(84.8%)相似。无论是否行 PORT,凸面非典型脑膜瘤患者的 5 年 PFS 率均为 100%。
GTR 后行 PORT 可能不能延长非典型脑膜瘤患者的 PFS。对于 GTR 后的非典型脑膜瘤患者,无论是否接受 PORT,凸面脑膜瘤患者均有良好的预后。